Navigation Links
Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
Date:4/12/2011

nsors by Phase 265

6.2 Patient Recruitment 266

7 Opportunity and Unmet Need 267

7.1 Unmet Need 267

7.2 Opportunity for Target Products 269

7.3 Key Takeaway 270

8 Strategic Assessment 271

8.1 Key Events Impacting the Future Market 271

8.2 Market Impact Analysis 272

8.3 Future Market Scenario 272

9 Gastric Cancer Market: Future Players 274

9.1 Introduction 274

9.2 Novartis AG 275

9.2.1 Business Description 275

9.2.2 Financial Overview 276

9.2.3 Gastric Cancer Pipeline 276

9.2.4 SWOT Analysis 277

9.3 GlaxoSmithKline 283

9.3.1 Business Description 283

9.3.2 Financial Overview 284

9.3.3 Gastric Cancer Pipeline 284

9.3.4 SWOT Analysis 285

9.4 Hoffmann-La Roche Ltd. 291

9.4.1 Business Description 291

9.4.2 Financial Performance 293

9.4.3 Gastric Cancer Pipeline 293

9.4.4 SWOT Analysis 294

9.5 Eli Lilly and Company 298

9.5.1 Business Description 298

9.5.2 Financial Overview 300

9.5.3 Gastric Cancer Pipeline 300

9.5.4 SWOT Analysis 301

9.6 Otsuka Holdings Co., Ltd./Otsuka Pharmaceutical Co., Ltd. 306

9.6.1 Business Description 306

9.6.2 Gastric Cancer Products 306

9.7 Merck KGaA 307

9.7.1 Business Description 307

9.7.2 Financial Overview 307

9.7.3 Gastric Cancer Pipeline 307

9.7.4 SWOT Analysis 308

10 Gastric Cancer Market: Players in the Gastric Cancer Market 313

10.1 Sanofi-aventis 313

10.1.1 Business Description 313

10.1.2 Financial Overview 315

10.1.3 SWOT Analysis 315

10.1.4 Oncology Focus 320

11 M&A Analysis 321

11.1 Key Highlights 321

11.2 Key Deals' Analysis 323

11.2.1 CrystalGenomics Completes Merger with BexPharm 323

11.2.2 Astellas Pharma Acquires OSI Pharmaceuticals 323

11.2.3 Eli Lilly Acquires ImClone 323'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Reportlinker Adds North America Neurology Devices Market Outlook to 2017
2. Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017
3. Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011
4. Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
5. Reportlinker Adds World In Vitro Diagnostics Market
6. Reportlinker Adds Global Market for Medical Devices, 2nd Edition
7. Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries)
8. Reportlinker Adds Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011
9. Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)
10. Reportlinker Adds Global: Pharmaceuticals Industry Guide
11. Reportlinker Adds Asian Vaccine Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  Parnell Pharmaceuticals Holdings Ltd announces the ... added to Parnell,s already extensive pipeline through a ... biotechnology company. The compounds now known as PAR ... bone regeneration and dermal regeneration, respectively. Parnell has ... the veterinary market with the potential to also ...
(Date:7/24/2014)... 24, 2014  Restore Health, a leading personalized ... announced that it is now offering pharmacogenetics testing ... individual based upon their particular genetic makeup. Comprehensive ... interaction between a patient,s genetics and their entire ... to provide this new service to healthcare providers ...
(Date:7/24/2014)... Germany , and MARSEILLE, France ... , Exclusive global license from University of Tokyo ... next-generation sequencing (NGS) gene panels, for blood cancers  ... new test, indicate favorable prognosis for patients with bone ... sees potential for developing companion diagnostics to guide treatment ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5
... 15 Concentra, the largest,occupational health care provider ... campaign to educate America,s workforce about the flu, ... it. The company expects to vaccinate,nearly 300,000 people ... in lost productivity. Concentra Medical Centers offers ...
... Patients with,mid-range coronary artery disease are more likely ... have repeat procedures if they get bypass,surgery rather than ... new report by the Agency for Healthcare Research and ... Services. The analysis drew on 23 randomized controlled ...
Cached Medicine Technology:Concentra Offers Flu Vaccines to Keep America Working 2Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease 2Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease 3
(Date:7/24/2014)... 24, 2014 Just as fitness and ... consider their own financial and marketing strength to be ... campaigns to the next level by using the most ... IVR, Voice Broadcast, Call Tracking and SMS texting ... rate, text messages are quickly become integral in marketing ...
(Date:7/24/2014)... July 24, 2014 CarePoint Health ... in hematology and oncology, Dr. Hitendra Upadhyaya, has ... system welcomes Dr. Upadhyaya to the community. Hundreds ... Health Medical Group, a comprehensive network of top ... wide range of specialties. This latest acquisition represents ...
(Date:7/24/2014)... found a way to delay or even prevent Alzheimer,s ... the anti-aging protein Klotho can prevent neuron death in ... These findings currently appear in the Journal of ... most frequent age-related dementia affecting 5.4 million Americans including ... more than 40 percent of people over the age ...
(Date:7/24/2014)... News) -- Drinking caffeine may worsen the hot flashes ... as they go through menopause, new survey data suggests. ... that limiting caffeine intake may be useful for those ... sweats," said researcher Dr. Stephanie Faubion, director of the ... Minn. But caffeine -- a stimulant found in ...
(Date:7/24/2014)... Hospital and the University of Tennessee Health Science Center ... drug shown to safely reduce the viral load and ... respiratory syncytial virus (RSV). RSV is the most common ... in the United States and worldwide. , The ... John DeVincenzo, MD. DeVincenzo,s Le Bonheur lab has been ...
Breaking Medicine News(10 mins):Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:RSV research breakthrough to help infected children 2
... ... - Gross margin expanded to 32.4 percent from ... Health management segment revenue grew 25 percent, - Net earnings: ... Nov. 3 Health Fitness,Corporation (NYSE Alternext US: FIT), a leading provider ...
... Held on Thursday November 6 at 8:30,a.m., NEW ... Board: VION) today announced financial,results for the three-month and ... a net loss of $6.8 million, or $0.92 per ... to a net loss,of $9.0 million, or $1.33 per ...
... neck, government study finds , , MONDAY, Nov. 3 (HealthDay ... with human papillomavirus (HPV) occurred in 38 states and ... officials reported Monday. , HPV is a group of ... than 30 of which can be sexually transmitted. Most ...
... A recent study conducted by researchers at Georgia ... demonstrate that administration of preemptive morphine prior to a ... of pain in adult rodents. These studies have ... administered to neonates prior to surgery. Infant rodents that ...
... Center at the University of California, San Diego (UCSD) ... at revving up the immune system to combat a ... therapy is being offered to patients with chronic lymphocytic ... resistant to initial treatment or harbors a particular chromosomal ...
... Revenue for the third quarter 2008 increases 32% to $16.0 million. - Heart ... surgical ablation products revenue grows 21.7%. ... Company raises lower end of its 2008 revenue guidance to $65 - $66 ... ...
Cached Medicine News:Health News:HealthFitness Announces 2008 Third Quarter Results 2Health News:HealthFitness Announces 2008 Third Quarter Results 3Health News:HealthFitness Announces 2008 Third Quarter Results 4Health News:HealthFitness Announces 2008 Third Quarter Results 5Health News:HealthFitness Announces 2008 Third Quarter Results 6Health News:HealthFitness Announces 2008 Third Quarter Results 7Health News:HealthFitness Announces 2008 Third Quarter Results 8Health News:HealthFitness Announces 2008 Third Quarter Results 9Health News:HealthFitness Announces 2008 Third Quarter Results 10Health News:Vion Reports 2008 Third Quarter and Nine-Month Results 2Health News:Vion Reports 2008 Third Quarter and Nine-Month Results 3Health News:Vion Reports 2008 Third Quarter and Nine-Month Results 4Health News:Vion Reports 2008 Third Quarter and Nine-Month Results 5Health News:U.S. Reported 25,000 Cases of HPV-Related Cancers Annually 2Health News:GSU study first to confirm long-term benefits of morphine treatment in infants 2Health News:Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients 2Health News:ATS Medical Announces Third Quarter Results 2Health News:ATS Medical Announces Third Quarter Results 3Health News:ATS Medical Announces Third Quarter Results 4Health News:ATS Medical Announces Third Quarter Results 5Health News:ATS Medical Announces Third Quarter Results 6Health News:ATS Medical Announces Third Quarter Results 7Health News:ATS Medical Announces Third Quarter Results 8
... is a basic laboratory system for pH ... can be obtained when used with a ... • Fast and easy one and two-point ... five buffers (pH 1.68, 4.00, 7.00, 10.01 ...
... Multimode Detectors provide unmatched value and ... and automation needs. Capable of performing ... the same instrument, the DTX Series ... can be integrated seamlessly with Beckman ...
... is a dual-monochromator, multi-detection microplate reader ... 6-384 microplate reading capability. Detection modalities ... intensity (FI) and have optical performance ... or spectrophotometer. Endpoint, kinetic, spectrum and ...
... microplate reader combines improved flexibility ... with a wide range of ... the flexibility, sensitivity and high ... is the ideal detection solution ...
Medicine Products: